Please login to the form below

Not currently logged in

virtual trials

This page shows the latest virtual trials news and features for those working in and with pharma, biotech and healthcare.

Entering the era of digital trials

Entering the era of digital trials

Connected inhalers provide comparable oversight of adherence for inhaled medications. Going virtual Individually, these technologies and many others in development stand to improve distinct parts of clinical trials. ... These obstacles to fully virtual

Latest news

  • Novartis pushes ‘virtual’ clinical trial concept Novartis pushes ‘virtual’ clinical trial concept

    process. The aim is to expand the number of ‘virtual’ trials it runs, with patients interacting with investigators via mobile phones and telemedicine devices rather than attending investigation sites in person. ... It’s already running semi-virtual

  • PatientsLikeMe launches 'virtual trial' in ALS PatientsLikeMe launches 'virtual trial' in ALS

    to eliminate many of the frustrations patients say are inherent in traditional clinical trials. ... Attempts to pursue virtual trials within pharma have had mixed success to date, with Pfizer's pioneering efforts in managing study participation

  • inVentiv invests in virtual trials

    Acquires equity stake in US-based Mytrus. Contract research organisation (CRO) inVentiv Health Clinical has acquired an equity stake in US-based 'virtual clinical trials' firm Mytrus. ... Mytrus, which was founded in 2009, has been developing

  • Pilot study combines patient-reported outcomes and medical records Pilot study combines patient-reported outcomes and medical records

    As direct-to-patient observational studies grow in number and size, experience and insights from these designs can be considered for integration into interventional clinical trials,” the researchers wrote in the

  • The virtual patient

    in the development of new drug treatments, and potentially rescuing compounds which have failed in trials. ... Using virtual patient models may allow drug developers to run many virtual clinical trials, but only require 20 patients or so for a

More from news
Approximately 2 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • A new era of smart pharma A new era of smart pharma

    Transforming the approach to drug development. Recruitment of subjects plus their management and monitoring within trials is challenging and several organisations have tried to conduct ‘virtual trials’ with limited success. ... Clearly protocol

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....